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1. Introduction 
A two-step mechanism for the mode of action of 
steroid hormones has been proposed [ 11. Some recent 
studies have indicated that the uptake of cytoplasmic 
progesterone receptor by isolated nuclei can be 
affected by certain inhibitors [2-S]. Aurintricarbox- 
ylic acid (ATA), a triphenylmethane dye, has been 
shown to interfere with the activities of DNA [6] and 
RNA polymerases [7]. It has been postulated that 
ATA combines with the template binding sites of 
these enzymes [LX]. We attempted to investigate if 
ATA would similarly interfere with the properties like 
nuclear uptake and DNA binding of estradiol recep- 
tor (ER) from hen oviduct. Identification and 
characterization of ER from chick oviduct has been 
reported [9,10]. 
2. Materials and methods 
2 .l . Preparation of estradiol receptor 
Oviducts from egg-laying white Leghorn hens were 
obtained from a local produce company and the 
receptor was prepared as in [ 11,121. 
2.2. Nuclear binding assay 
Nuclei were isolated from hen oviduct tissue by 
the method in [ 131. Nuclear assay consisted of incu- 
bation of hormone receptor complexes with ATA or 
buffer followed by the addition of a nuclear aliquot 
containing about 50 pg DNA [2,13]. DNA was quan- 
titated by the method in [ 141. 
2.3. Affinity chromatography 
Samples containing ER complexes were chromato- 
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graphed on short columns of ATP-Sepharose [ 11 ,121 
or DNA-cellulose [ 151. Columns were washed with 
low salt buffers (Tris 10 mM, 1 mM EDTA, 12 mM 
thioglycerol (pH 8.0) with 0.01 M KCI) or same 
buffer containing 1 M KCl. All buffers contained 
20% glycerol. 
3. Results and discussion 
Figure 1 shows our results on nuclear uptake of 
ER. Binding of ER complexes to isolated hen oviduct 
nuclei showed a dramatic decrease (-60%) when 
incubated in presence of 0.5 mM ATA. Comparable 
results were obtained when lower (0.1-0.2 mM) ATA 
concentrations were used in several experiments. The 
steroid binding properties of ER, however, remained 
intact (data not shown). These results indicate that 
ATA interferes with the nuclear binding properties 
of ER, possibly complexing to a site or sites on 
receptor protein involved in such processes. 
A DNA binding site for the steroid receptors has 
been postulated [15-l 71. In our studies, when ER 
complexes were allowed to mix with DNA-cellulose 
in a form of slurry with and without a pretreatment 
of 0.3 mM ATA, the binding of ER to DNA was 
reduced by about 50% in samples pretreated with 
ATA. In other studies, ATA has been known to 
reduce specifically the affinity of RNA directed 
DNA polymerase for the DNA primer molecule [ 181. 
In addition, ATA has been suggested to combine 
with the template binding sites of nucleic acid bind- 
ing proteins [ 181. Our results indicate that ATA may 
also be binding to a DNA binding site of ER molecule, 
thus blocking interaction with DNA. 
Earlier studies have demonstrated an interaction 
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Fig.1. Effect of ATA on the nuclear uptake and DNA bind- 
ing of ER. (A) Receptor preparation was incubated with 
10 nM [ ‘Hlestradiol (98.5 Ci/mmol; New England Nuclear) 
in total vol. 0.5 ml and with 20% glycerol. Samples were 
then treated with buffer or 0.5 mM ATA. After 2 h at 4”C, 
50 ~1 aliquots of isolated hen oviduct nuclei containing 50 gg 
DNA were added and tubes mixed gently for 1 h. The nuclear 
binding assays were performed as in [ 13 1. (B) ER complexes 
were treated with a 0.5% charcoal suspension to remove free 
hormone and then incubated with or without ATA (0.3 mM) 
for 1 h at 4°C. A batch assay was used to monitor DNA 
binding of ER. Samples were incubated with DNAcellulose, 
and the affinity resin was washed with TETG buffer con- 
taining 0.01 M KC1 and 20% glycerol (pH 8.0). The ER com- 
plexes were recovered by stirring the resin with same buffer 
but containing 1 M KCl. Supernatants, upon centrifugation at 
1000 X g. were used to measure radioactivity. 
between ATP and steroid receptors [ 11,12,19]. The 
binding of ATP has been shown to be a property of 
activated receptor. In the present studies, we demon- 
strate an interaction of ER from hen oviduct with 
ATP, which is also sensitive to the presence of low 
concentrations of ATA (fig.2). A pretreatment of ER 
complexes with ATA eliminated almost entire bind- 
ing of ER complexes to ATP-Sepharose. These 
results support some preliminary observations report- 
ing an interaction of ATP with progesterone receptor 
which was affected by ATA presence [3,20]. 
A nucleotide binding site could be closely related to 
nuclear and DNA binding sites of ER. An interference 
by ATA in all of the above properties which represent 
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Fig.2. Effect of ATA on binding of ER to ATP-Sepharose. 
The [‘H Jestradiol(10 nM) was complexed to ER for 16 h 
and the complexes were then incubated with their TETG 
buffer (o-0) or 0.5 mM ATA (a- -0) for 2 h at 4°C. 
Following this, the entire samples (0.5 ml) were chromato- 
graphed on short (1 ml) columns of ATP-Sepharose. Affinity 
columns were equilibrated with TETG 0.01 M KC1 buffer 
with 20% glycerol and 15 fractions were collected with same 
buffer. The ER complexes were then eluted with same 
buffer but containing 1 M KCI. The procedures for column 
chromatography were essentially same as described earlier 
[ 11 ,121. The lines at the beginning, prior to the appearance 
of the peak, represent excess free hormone plus the amount 
of estradiol receptor complex not retained by the ATP- 
Sepharose. 
important events in hormone action could be of 
immense importance. ATA does not destroy the 
steroid binding characteristics of ER, suggesting a 
preferential blockage of nuclear events. Efforts are 
underway to show, by direct binding studies, a bind- 
ing site for ATA on the receptor molecule.The ques- 
tion, however, remains whether ATA binds to one 
site and alters different functional parameters of 
receptor or it binds at different but related sites 
involved in those processes. 
ATA has been used to block the activities of poly- 
merases [6-8 1. Similarities between polymerases and 
steroid receptors have been suggested based on the 
effects of several compounds which inhibit both poly- 
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merases and progesterone receptor like ATP, nuclear 
and DNA binding. Moreover, highly purified pro- 
gesterone receptor has been shown to catalyze metab- 
olism of ATP to AMP and pyrophosphate (PPi) by a 
PPi-exchange reaction which is a common property 
of nucleotidyl transferases [21]. These studies are 
also consistent with an earlier prediction that ER may 
be a metalloprotein [22]. Incidentally most DNA and 
RNA polymerases are known to be metalcontaining 
enzymes. Although the mode of action of steroid 
hormones is still obscure, our studies suggest similari- 
ties between polymerases and ER, at least based on 
the effects of ATA and other inhibitors [2,18,20,21]. 
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